NASDAQ · LFMDPHealthcareOffices & Clinics — Doctors

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock news

$23.15−0.22%
Close Sep 25, 2026 · split-adjusted
Articles · 30 days1English, de-duplicated
Positive1100% of coverage
Neutral00%
Negative00% of coverage

About LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock

No recent articles focused on LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock.

Also mentions LFMDP

Articles that tag LFMDP but are mainly about other companies.

LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
GlobeNewswire Inc.Jun 22, 8:00 AM ET▲ Positive

LifeMD secured an exclusive telehealth partnership with a major pharmaceutical company, expanding its service offerings and market reach. The collaboration leverages LifeMD's existing infrastructure (medical group, pharmacy, patient care center) to enter a new therapeutic area, potentially creating a new revenue stream and positioning the company as a leader in virtual specialty care delivery.

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
BenzingaMar 24, 4:05 PM ETNeutral

The dividend declaration is a routine corporate action that demonstrates the company's ability to maintain preferred dividend payments. However, the announcement itself contains no information about business performance, growth, or operational changes that would warrant a positive or negative sentiment. It is a standard financial obligation being met.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology